Peter Casasanto
Corporate Officer/Principal bei SOPHIA GENETICS SA
Aktive Positionen von Peter Casasanto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SOPHIA GENETICS SA | Corporate Officer/Principal | 10.01.2022 | - |
Karriereverlauf von Peter Casasanto
Ehemalige bekannte Positionen von Peter Casasanto
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - | - |
Ausbildung von Peter Casasanto
Lebow College of Business | Masters Business Admin |
Thomas Jefferson University | Graduate Degree |
University of Maryland | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Schweiz | 2 |
Kanada | 2 |
Operativ
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Graduate Degree | 1 |
Sektoral
Consumer Services | 4 |
Technology Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SOPHIA GENETICS SA | Technology Services |
Private Unternehmen | 1 |
---|---|
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
- Börse
- Insiders
- Peter Casasanto
- Erfahrung